ArcticZymes granted NOK 1.6 million funding from Innovation Norway for enzyme development project.
(World News Science)

ArcticZymes granted NOK 1.6 million funding from Innovation Norway for enzyme development project. Tromsø, Norway, 28. May 2020 - Biotec Pharmacon (OSE: Biotec) announces its subsidiary, ArcticZymes AS, has been granted by Innovation Norway up to NOK 1.6 million for a project to commercialize additional enzyme components required by diagnostic developers. ArcticZymes Cod UNG enzyme offers diagnostic developers a superior enzyme-based solution for preventing false-positive results without affecting sensitivity in molecular diagnostic tests. Since the commercialization of Cod UNG in 2004, the enzyme has been integrated into a broad range of diagnostic tests by commercial partners. Furthermore,...